Core Viewpoint - The company has successfully completed small batch orders for its flexible sensors, indicating strong market recognition and demand in the industrial inspection and robotics sectors [1] Group 1 - The company's flexible sensor (electronic skin) pilot line has reached operational status and is now in production [1] - The company has engaged with leading clients in the industrial inspection and robotic dexterous hand fields, achieving high levels of technical and market recognition [1] - The pilot line is capable of meeting current market demands, and the company plans to adjust production capacity in response to market changes [1]

Overview of the Announcement - The company has approved the transfer of assets, liabilities, and personnel from its Yantai branch to its wholly-owned subsidiary, Yantai Fulai New Materials Technology Co., Ltd, along with a capital increase for the subsidiary [2][3] Asset and Liability Transfer - The transfer involves the Yantai branch's total assets amounting to 628.24 million yuan and liabilities of 635.11 million yuan, resulting in a net asset value of -6.88 million yuan as of April 30, 2025 [3] - The transfer will be executed at book value, and any changes in assets and liabilities from the transfer date to the actual transfer date will be adjusted accordingly [3] Capital Increase Details - The company will increase the registered capital of Yantai Fulai by 350 million yuan, with the remaining 6.88 million yuan allocated to the capital reserve [4] - Post-increase, the registered capital of Yantai Fulai will rise from 30 million yuan to 380 million yuan, maintaining the company's 100% ownership [4] Employee Transition - All employees from the Yantai branch will be transferred to Yantai Fulai, following the principle of "people move with assets and business" [6] - Necessary procedures for re-signing labor contracts and transferring social insurance will be conducted in compliance with relevant laws and regulations [6] Contractual Obligations - The company will handle the transfer of rights and obligations related to existing contracts and agreements to Yantai Fulai, while any agreements that cannot be transferred will remain the responsibility of the company [7] Corporate Compliance - Both companies have confirmed their legal status and compliance with necessary authorizations for signing the transfer agreement [8][9] Business Registration Update - Yantai Fulai has completed the business registration for the capital increase and received a new business license, with the updated registered capital now at 380 million yuan [10] Impact on the Company - The transfer of assets and liabilities is a reallocation within the consolidated financial statements and will not significantly impact the company's financial or operational status [11]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、本次划转情况概述 浙江福莱新材料股份有限公司（以下简称"公司"）于 2025 年 3 月 27 日召开 第三届董事会第八次会议、第三届监事会第七次会议审议通过了《关于将分公司 资产、负债及人员划转至全资子公司并对全资子公司增资暨变更部分募投项目实 施主体的议案》，同意将浙江福莱新材料股份有限公司烟台分公司（以下简称"烟 台分公司"）相关的资产及负债划转至公司全资子公司烟台福莱新材料科技有限 公司（以下简称"烟台福莱公司"），并对烟台福莱公司进行增资，按照"人随业务 走"原则进行人员安置。具体内容详见公司 2025 年 3 月 29 日披露于上海证券交 易所网站（www.sse.com.cn）及指定信息披露媒体的《福莱新材关于将分公司资 产、负债及人员划转至全资子公司并对全资子公司增资暨变更部分募投项目实施 主体的公告》。 | 证券代码：605488 | 证券简称：福莱新材 | 公告编号：临 | 2025-073 | | --- | --- | --- | --- | | 债券 ...

Group 1 - Company Sun Energy plans to repurchase shares worth between 100 million to 200 million yuan for cancellation, with a maximum repurchase price of 6.69 yuan per share [1] - Company Runyang Technology intends to invest up to 300 million yuan in Shanghai Fourier Intelligent Technology Co., with a pre-investment valuation of 8 billion yuan [1] - Company Heng Rui Medicine's subsidiary has received approval for clinical trials of SHR-4712 injection for treating advanced solid tumors [2] Group 2 - Company Lianhuan Pharmaceutical plans to increase capital by 60 million yuan for its wholly-owned subsidiary [2] - Company Hongchang Electronics' subsidiary plans to increase capital by 10 million USD for its other subsidiary [2] - Company Sichuan Meifeng intends to repurchase shares worth between 50 million to 70 million yuan for cancellation, with a maximum repurchase price of 10.07 yuan per share [2] Group 3 - Company Lian Micro plans to liquidate and deregister Jiaxing Kangjing Semiconductor Industry Investment Partnership [4] - Company Jiutian Pharmaceutical has received approval for clinical trials of PDX-04 drug for treating acute gout attacks [5] - Company Pingzhi Information has signed a framework agreement with China Telecom for a GPU computing power project worth approximately 246 million yuan [7] Group 4 - Company Jiu Zhi Tang's subsidiary has initiated Phase II clinical trials for new drug YB211 aimed at treating acute bacterial skin infections [8] - Company Fosun Pharma's subsidiary has received orphan drug designation for HLX22 for gastric cancer treatment in the EU [9] - Company Jianyou Co. plans to repurchase shares worth between 20 million to 40 million yuan for employee stock ownership plans [11] Group 5 - Company Zhi Zheng Co. announced the resignation of its vice president due to personal reasons [13] - Company He Mai Co. signed a cooperation agreement for household photovoltaic systems worth 1 billion yuan [14] - Company Jinan Intelligent's subsidiary won a project bid for electric vehicle charging stations, expected to positively impact performance [16] Group 6 - Company Gaotie Electric plans to distribute a cash dividend of 0.012 yuan per share [18] - Company Guyue Longshan plans to distribute a cash dividend of 0.08 yuan per share [18] - Company Yongmaotai's shareholders plan to reduce their holdings by up to 2.66% of the company's shares [19] Group 7 - Company Tian Cheng Technology's subsidiary received a land idle fee notice for 2.1658 million yuan due to project delays [20] - Company Guangri Co. appointed a new vice president and board secretary to enhance governance [21] - Company Design General Institute won multiple major projects totaling approximately 390 million yuan [22] Group 8 - Company Fuxie Environmental signed a significant contract worth 244 million yuan for a sewage treatment project [23] - Company Lujiazui announced the resignation of its vice chairman due to job transfer [24] - Company Three Squirrels' H-share issuance application has been accepted by the CSRC [24] Group 9 - Company Kanghong Pharmaceutical's subsidiary received approval for clinical trials of KH617 for glioblastoma treatment [25] - Company Xin Zhu Co. announced a suspension of trading to plan an asset acquisition from its controlling shareholder [26] - Company Jianxin Co. announced plans for share reductions by several directors and senior management [28]

Core Viewpoint - The legal opinion letter issued by Beijing Junhe (Hangzhou) Law Firm confirms that Zhejiang Fulai New Materials Co., Ltd.'s differentiated dividend distribution plan for 2024 complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [9][10]. Group 1: Differentiated Dividend Distribution - The differentiated dividend distribution is based on the company's total share capital after deducting shares held in the repurchase account, with a cash dividend of 1.50 RMB per 10 shares (tax included) and a capital reserve increase of 4 shares per 10 shares [3][5]. - As of May 22, 2025, the total share capital of the company is 201,645,186 shares, with 2,426,950 shares in the repurchase account not participating in the profit distribution [4][5]. - The total cash dividend expected to be distributed amounts to approximately 79,687,294 shares based on the differentiated dividend plan [4][5]. Group 2: Legal Compliance and Verification - The law firm verified that the company provided all necessary documents and guarantees regarding the authenticity and completeness of the information for the legal opinion [2][3]. - The legal opinion is solely for the purpose of the differentiated dividend distribution and does not cover financial accounting or auditing matters [2][3]. - The law firm confirms that the differentiated dividend distribution aligns with the provisions of the Company Law, Securities Law, and relevant regulatory guidelines [9][10]. Group 3: Impact on Stock Price - The reference price for ex-dividend (ex-rights) is calculated based on the closing price of 44.93 RMB per share, adjusted for the cash dividend and the change in circulating shares [6][7]. - The actual distribution will result in a minor impact on the ex-dividend reference price, with an absolute value of impact below 1% [8].

Core Viewpoint - The company announced an adjustment to the conversion price of its convertible bonds due to the implementation of the 2024 annual equity distribution, resulting in a new conversion price of 9.54 CNY per share from the previous 13.46 CNY per share [2][5]. Group 1: Equity Distribution and Conversion Price Adjustment - The company will distribute a cash dividend of 1.50 CNY per 10 shares and will increase capital by 4 shares for every 10 shares held [3][5]. - The adjustment to the conversion price is based on the formula outlined in the company's prospectus, which accounts for changes in share capital due to equity distribution [3][4]. - The new conversion price will take effect on May 30, 2025, after a suspension of conversion from May 23 to May 29, 2025 [2][6]. Group 2: Details of the Convertible Bonds - The company issued 4.29018 million A-share convertible bonds with a total issuance amount of 429.018 million CNY on January 4, 2023 [2][3]. - The bonds have a maturity period from January 4, 2023, to January 3, 2029, with a conversion period specified [2][3].

Core Viewpoint - Zhejiang Fulai New Materials Co., Ltd. announced its 2024 annual profit distribution plan, which includes a cash dividend and a capital increase through stock transfer [2][4]. Summary by Sections Profit Distribution and Capital Increase - The company plans to distribute a cash dividend of 1.50 RMB per 10 shares (including tax) and to increase capital by transferring 4 shares for every 10 shares held [2][3]. - The total number of shares participating in the distribution is 199,218,236 shares after excluding 2,426,950 shares held in the company's repurchase account [2][3]. Important Dates - The key dates for the distribution are as follows: - Equity registration date: May 29, 2025 - Last trading date: May 30, 2025 - Ex-dividend date: May 30, 2025 [5][4]. Tax Implications - For individual shareholders holding shares for over one year, the cash dividend is exempt from personal income tax, resulting in a net distribution of 0.15 RMB per share [6][7]. - For shares held for less than one month, a 20% tax applies, while shares held between one month and one year are taxed at 10% [7][8]. Share Capital Structure Changes - The total share capital before the distribution is 201,645,186 shares, which will increase to 281,332,480 shares after the capital increase [10]. - The diluted earnings per share for the fiscal year 2024 is projected to be 0.54 RMB after the capital increase [10]. Adjustments to Convertible Bonds - The company will adjust the conversion price of its convertible bonds in accordance with the changes in share capital due to the profit distribution [11].

Core Viewpoint - The company, Zhejiang Fulai New Materials Co., Ltd., has announced adjustments to its 2024 profit distribution cash dividend total and capital reserve fund increase in share capital total due to changes in total share capital resulting from the conversion of convertible bonds [1][2][3] Summary of Key Points Cash Dividend Adjustment - The total cash dividend amount has been adjusted to RMB 29,882,735.40 (including tax) [1][4] - The cash dividend distribution is set at RMB 1.50 (including tax) for every 10 shares [2][4] Capital Reserve Fund Increase - The number of shares to be increased from the capital reserve fund has been adjusted from 79,587,325 shares to 79,687,294 shares [1][5] - After the increase, the total share capital of the company will rise to 281,332,480 shares [1][5] Reason for Adjustment - The adjustments were necessitated by changes in total share capital due to the conversion of the "Fuxin Convertible Bonds" prior to the equity distribution registration date [2][3] - As of May 22, 2025, the total share capital increased from 201,395,263 shares to 201,645,186 shares due to the conversion [2][3] Profit Distribution Plan Overview - The profit distribution plan was approved at the annual shareholders' meeting on April 23, 2025, with the base for distribution calculated after deducting shares in the repurchase account [2][3] - The adjusted total cash dividend and share increase are based on the new total share capital after accounting for the repurchase account [4][5]

Fundraising Overview - The company Zhejiang Fulai New Materials Co., Ltd. has successfully completed its initial public offering (IPO) by issuing 30 million shares at a price of 20.43 RMB per share, raising a total of 612.9 million RMB, with a net amount of 530.63 million RMB after deducting issuance costs [1][2]. Fund Management and Regulatory Compliance - The company has signed a four-party supervision agreement for the storage of fundraising special accounts to ensure proper management of the raised funds and protect investor rights, in accordance with relevant laws and regulations [3][4]. - The agreement involves the company, its wholly-owned subsidiary Yantai Fulai New Materials Technology Co., Ltd., China Construction Bank, and CITIC Securities as the sponsor [4][5]. Fund Allocation and Usage - The special account will be exclusively used for the "New Materials Project" previously managed by the Yantai branch, which has now been transferred to the subsidiary [4][5]. - The company is authorized to invest a portion of the funds in cash management products, with strict regulations on the usage and management of these funds to ensure compliance with the Shanghai Stock Exchange guidelines [4][5]. Monitoring and Reporting - The sponsor (CITIC Securities) will conduct ongoing supervision of the fundraising management, including on-site inspections and inquiries, to ensure compliance with the agreement [5][6]. - Any expenditures from the special account must be reported to the sponsor within three working days, along with a detailed expenditure list [6][7].

Group 1 - The company, Zhejiang Fulai New Materials Co., Ltd., has announced a change in its continuous supervision sponsor representative due to the work changes of the previous representative, Sun Qi [1][2] - CITIC Securities has been the sponsor for the company's IPO in 2021 and the issuance of convertible bonds in 2022, with the statutory supervision period ending on December 31, 2024 [1][2] - The new sponsor representative, Kong Lei, has extensive experience in investment banking and has participated in various IPO and refinancing projects [2] Group 2 - The previous sponsor representatives were Zhang Yujie and Sun Qi, with Sun Qi being replaced by Kong Lei to ensure the orderly continuation of supervision work [2] - Kong Lei has been involved in multiple projects, including IPOs and convertible bond issuances for various companies, indicating a strong background in the field [2]